Price Capital Management, Inc. - PROGENICS PHARMACEUTICALS IN ownership

PROGENICS PHARMACEUTICALS IN's ticker is PGNX and the CUSIP is 743187106. A total of 123 filers reported holding PROGENICS PHARMACEUTICALS IN in Q2 2015. The put-call ratio across all filers is 0.26 and the average weighting 0.1%.

Quarter-by-quarter ownership
Price Capital Management, Inc. ownership history of PROGENICS PHARMACEUTICALS IN
ValueSharesWeighting
Q1 2015$218,00036,4490.14%
Other shareholders

There were no reported owners of PROGENICS PHARMACEUTICALS IN in Q2 2015.

NameSharesValueWeighting ↓
View complete list of PROGENICS PHARMACEUTICALS IN shareholders